Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Mar 13, 2018 · 10-K · 72 days after period end · 0001564590-18-005384
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016 | Q4 2015 |
|---|---|---|---|
| Revenue | $2.82M | $8.77M | $8.29M |
| Net Income | -$9.76M | -$14.95M | -$17.90M |
| EPS Diluted | — | -$0.74 | -$0.88 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 13, 2018 · 72 d after period end
